Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q
Authors:
- 24 February 2015
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 29 (9) , 1942-1945
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDSCancer Cell, 2014
- Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In VivoCancer Cell, 2014
- Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemiaJournal of Experimental Medicine, 2014
- Extended survival and reduced risk of AML progression in erythroid-responsive lenalidomide-treated patients with lower-risk del(5q) MDSLeukemia, 2013
- SETBP1 mutation analysis in 944 patients with MDS and AMLLeukemia, 2013
- Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromesNature Genetics, 2011
- Prognostic Significance ofASXL1Mutations in Patients With Myelodysplastic SyndromesJournal of Clinical Oncology, 2011
- TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease ProgressionJournal of Clinical Oncology, 2011
- Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotypeNature Medicine, 2009
- Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arraysHaematologica, 2008